Bacterial Cystitis

Bacterial cystitis is an inflammatory condition of the urinary bladder caused by bacterial infection. It is a common lower urinary tract disease in dogs and cats, characterized by the presence of bacteriuria, pyuria, and hematuria, along with clinical signs such as pollakiuria, dysuria, and stranguria. The condition can be acute or chronic, uncomplicated or complicated, and may involve the upper urinary tract (pyelonephritis) in severe cases. Bacterial cystitis is often secondary to underlying predisposing factors, including anatomical abnormalities, urolithiasis, neoplasia, or immunosuppression. In veterinary medicine, the term 'bacterial cystitis' is used to describe inflammation of the bladder wall due to bacterial invasion, which can lead to mucosal damage, edema, and hemorrhage. The disease is classified based on the presence of complicating factors: uncomplicated cystitis occurs in otherwise healthy animals with normal urinary tract anatomy and function, while complicated cystitis is associated with structural or functional abnormalities, concurrent diseases (e.g., diabetes mellitus, hyperadrenocorticism), or recurrent infections. The systemic relevance of bacterial cystitis is generally limited, but ascending infection can lead to pyelonephritis, bacteremia, and sepsis, particularly in immunocompromised patients. Early diagnosis and appropriate antimicrobial therapy are essential to prevent complications and recurrence.

The primary causative agents of bacterial cystitis are bacteria, with Escherichia coli being the most common isolate, accounting for approximately 40-50% of cases in dogs and cats. Other frequently isolated bacteria include Staphylococcus spp. (especially Staphylococcus pseudintermedius), Streptococcus spp., Enterococcus spp., Proteus mirabilis, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Corynebacterium urealyticum. In cats, E. coli and Staphylococcus spp. are also common, but Enterococcus and Streptococcus are increasingly recognized. Less common pathogens include Mycoplasma spp., Ureaplasma spp., and fungal organisms (e.g., Candida spp.) in immunocompromised patients. The virulence factors of uropathogenic E. coli (UPEC) include adhesins (e.g., P fimbriae, type 1 fimbriae), toxins (e.g., hemolysin, cytotoxic necrotizing factor), and siderophores (e.g., aerobactin), which facilitate adherence to uroepithelial cells, invasion, and biofilm formation. Transmission is typically ascending from the distal urethra and perineum, with fecal flora being the primary source. Hematogenous spread is rare but possible in immunocompromised animals. Environmental factors, such as poor hygiene, urinary catheterization, and perineal contamination, contribute to bacterial entry. In addition, underlying conditions that alter the urinary tract's defense mechanisms, such as urolithiasis, neoplasia, or anatomical abnormalities, predispose to bacterial colonization and infection.

Bacterial cystitis is a common diagnosis in small animal practice, with an estimated prevalence of 14% in dogs and 3% in cats presenting with lower urinary tract signs. Female dogs are more commonly affected than males due to a shorter, wider urethra, which facilitates ascending bacterial migration. The risk increases with age, with a peak incidence in middle-aged to older animals. Certain breeds may have a genetic predisposition, such as the Dalmatian (due to urate urolithiasis), the Miniature Schnauzer (due to hyperlipidemia and urolithiasis), and the Bichon Frise (due to a higher incidence of urolithiasis). In cats, bacterial cystitis is less common than feline idiopathic cystitis, but it is more frequently diagnosed in older cats, particularly those with chronic kidney disease, diabetes mellitus, or hyperthyroidism. Geographic variations exist, with warmer climates potentially increasing the risk of urolithiasis and subsequent infection. Seasonality is not well-documented, but urinary tract infections may be more common in summer months due to increased water intake and dilution of urine, which can alter bacterial growth dynamics. Indoor cats may have a higher risk of urinary tract disease due to stress and reduced water intake, but bacterial cystitis specifically is not strongly associated with indoor status. Recurrent bacterial cystitis is a significant clinical problem, with recurrence rates of 20-30% in dogs and 10-20% in cats within one year of initial treatment.

The pathophysiology of bacterial cystitis involves a complex interplay between bacterial virulence factors and host defense mechanisms. The urinary bladder is normally protected by several innate defenses, including the flushing action of urine, the glycosaminoglycan (GAG) layer on the urothelium, the secretion of antimicrobial peptides (e.g., defensins), and the local immune response. Bacterial invasion begins with colonization of the periurethral area and ascent into the bladder. Uropathogenic bacteria, particularly E. coli, express adhesins that bind to specific receptors on uroepithelial cells, allowing them to resist the shear forces of urine flow. Once attached, bacteria can invade the superficial umbrella cells, forming intracellular bacterial communities (IBCs) that serve as reservoirs for recurrent infection. The host inflammatory response is triggered by bacterial components, such as lipopolysaccharide (LPS), which activate Toll-like receptors (TLRs) on uroepithelial cells and macrophages, leading to the release of pro-inflammatory cytokines (e.g., IL-6, IL-8, TNF-α). This results in vasodilation, increased vascular permeability, and recruitment of neutrophils to the bladder wall. Neutrophils release reactive oxygen species and proteolytic enzymes, causing tissue damage and contributing to the clinical signs of dysuria and hematuria. Chronic or recurrent infections can lead to mucosal hyperplasia, fibrosis, and the formation of biofilm, which protects bacteria from antimicrobial therapy and host immune responses. In complicated cases, bacteria can ascend to the kidneys, causing pyelonephritis, which may result in renal parenchymal damage, fibrosis, and impaired renal function. Systemic spread can occur, leading to bacteremia and sepsis, particularly in immunocompromised patients.

Predisposing factors for bacterial cystitis can be intrinsic or extrinsic. Intrinsic factors include anatomical abnormalities such as ectopic ureters, urachal remnants, vaginal strictures, and urethral diverticula, which disrupt normal urine flow and allow bacterial colonization. Functional abnormalities, such as detrusor atony or urethral sphincter incompetence, lead to urine retention and stasis, increasing the risk of infection. Metabolic disorders, including diabetes mellitus, hyperadrenocorticism, and chronic kidney disease, alter the urinary environment (e.g., glucosuria, dilute urine) and impair immune function. Immunosuppression, whether due to disease (e.g., feline leukemia virus, feline immunodeficiency virus) or drug therapy (e.g., corticosteroids, chemotherapy), reduces the host's ability to clear bacteria. Age is a risk factor, with older animals having decreased immune function and increased incidence of urolithiasis and neoplasia. Extrinsic factors include poor hygiene, perineal contamination, and the use of indwelling urinary catheters, which provide a direct route for bacterial entry. Catheter-associated urinary tract infections are a major concern in hospitalized patients, with the risk increasing with the duration of catheterization. Dietary factors, such as high magnesium or phosphorus content, can promote urolithiasis, which in turn predisposes to infection. Stress, particularly in cats, can lead to behavioral changes and reduced water intake, concentrating urine and decreasing the flushing effect. In addition, prior antimicrobial therapy can disrupt the normal flora and select for resistant bacteria, increasing the risk of recurrent or complicated infections.

Clinical signs of bacterial cystitis are typically related to lower urinary tract inflammation and include pollakiuria (increased frequency of urination), dysuria (painful or difficult urination), stranguria (straining to urinate), hematuria (blood in the urine), and inappropriate urination (urinating outside the litter box or in unusual places). In dogs, owners may notice frequent attempts to urinate with small volumes, or urine dribbling. In cats, signs may be subtle and include urinating on smooth surfaces (e.g., tile, bathtub) or increased vocalization during urination. Physical examination may reveal a thickened, painful bladder on palpation, and in severe cases, the bladder may be small and contracted. Systemic signs are uncommon in uncomplicated cystitis but may include lethargy, fever, and anorexia if pyelonephritis or sepsis develops. In chronic cases, weight loss and poor coat condition may be observed. The clinical signs can be categorized by stage: peracute (sudden onset of severe dysuria and hematuria), acute (classic signs lasting less than 7 days), subacute (signs persisting for 1-2 weeks), chronic (signs lasting more than 2 weeks or recurrent episodes), and terminal (signs associated with complications such as urosepsis or renal failure). Early indicators may include subtle changes in urination behavior, such as increased frequency or straining, which should prompt further investigation.

Differential diagnoses for bacterial cystitis include other causes of lower urinary tract disease. These include: 1) Feline Idiopathic Cystitis (FIC): A diagnosis of exclusion in cats, characterized by similar clinical signs but with no identifiable bacterial infection, urolithiasis, or anatomical abnormality. Key differentiating features: absence of significant bacteriuria and pyuria on urinalysis, and a history of stress or environmental factors. 2) Urolithiasis: The presence of urinary calculi (e.g., struvite, calcium oxalate) can cause mechanical irritation and secondary bacterial infection. Diagnosis is confirmed by imaging (radiography, ultrasonography) and urinalysis (crystalluria). 3) Urinary Tract Neoplasia: Transitional cell carcinoma (TCC) is the most common bladder tumor in dogs, and can present with hematuria and dysuria. Key features: older animals, palpable mass on abdominal palpation, and imaging findings of a mass lesion. 4) Anatomical Abnormalities: Ectopic ureters, urachal remnants, and vaginal strictures can cause urinary incontinence and recurrent infections. Diagnosis is made via contrast radiography, ultrasonography, or cystoscopy. 5) Neurogenic Bladder Dysfunction: Conditions such as detrusor atony or urethral sphincter incompetence can lead to urine retention and infection. Diagnosis is based on neurological examination and urodynamic studies. 6) Chronic Kidney Disease (CKD): Although primarily a renal disease, CKD can cause polyuria and dilute urine, which may be mistaken for lower urinary tract signs. Key features: elevated SDMA and creatinine, isosthenuria, and proteinuria. 7) Prostatitis (in male dogs): Infection of the prostate gland can cause dysuria and hematuria, and may be associated with systemic signs. Diagnosis is based on prostatic palpation, ultrasonography, and semen culture. 8) Vaginitis (in female dogs): Inflammation of the vagina can cause dysuria and perineal irritation, but urinalysis is typically normal. 9) Trauma: Blunt or penetrating trauma to the bladder can cause hematuria and dysuria, but a history of trauma and imaging findings (e.g., free abdominal fluid) are key. 10) Drug-Induced Cystitis: Certain drugs, such as cyclophosphamide, can cause sterile hemorrhagic cystitis. A history of drug administration and absence of bacteriuria are key.

The diagnostic algorithm for bacterial cystitis begins with a thorough history and physical examination. If lower urinary tract signs are present, the next step is a complete urinalysis, including urine specific gravity, dipstick analysis, and microscopic sediment examination. The presence of bacteriuria, pyuria, and hematuria supports a diagnosis of bacterial cystitis, but a urine culture is required for definitive diagnosis and antimicrobial susceptibility testing. In cases of uncomplicated cystitis, a urine culture is recommended, but empirical therapy may be initiated based on common pathogens and local resistance patterns. For complicated or recurrent cases, a urine culture should always be performed. If urolithiasis or anatomical abnormalities are suspected, imaging studies such as abdominal radiography and ultrasonography are indicated. Radiography can detect radiopaque uroliths (e.g., struvite, calcium oxalate), while ultrasonography is useful for evaluating bladder wall thickness, masses, and uroliths that are not radiopaque. In cases of recurrent infection, cystoscopy may be performed to visualize the bladder mucosa and obtain biopsy samples. If pyelonephritis is suspected, additional tests include complete blood count, serum biochemistry, and urine culture from the renal pelvis (via pyelocentesis) or a positive urine culture with concurrent renal pelvic dilation on ultrasonography. The diagnostic algorithm should also include assessment for underlying predisposing factors, such as endocrine testing (e.g., cortisol:creatinine ratio for hyperadrenocorticism) and imaging for urolithiasis. In cats, ruling out feline idiopathic cystitis is important, as it is the most common cause of lower urinary tract signs in this species.

Laboratory findings in bacterial cystitis are primarily based on urinalysis and urine culture. Urinalysis typically reveals a urine specific gravity that may be normal or dilute, depending on the underlying cause. Dipstick analysis may show positive results for blood (hematuria), protein (proteinuria), and nitrites (though nitrites are not reliable in dogs and cats). Microscopic sediment examination is crucial and may reveal increased numbers of white blood cells (pyuria), red blood cells (hematuria), and bacteria (bacteriuria). The presence of bacteria on sediment examination is not always reliable, as some bacteria may be missed or confused with debris. Urine culture is the gold standard for diagnosis, with a positive culture (typically >10^3 CFU/mL in dogs and >10^4 CFU/mL in cats, though lower counts may be significant in certain cases) confirming bacterial infection. Antimicrobial susceptibility testing should be performed to guide therapy. Complete blood count (CBC) may be normal in uncomplicated cases, but may show leukocytosis with a left shift in cases of pyelonephritis or sepsis. Serum biochemistry may reveal elevated renal parameters (creatinine, SDMA) if pyelonephritis is present, and may also identify underlying conditions such as hyperglycemia (diabetes mellitus) or hypercortisolemia (hyperadrenocorticism). Blood gas analysis may show metabolic acidosis in cases of sepsis or renal failure. Specific biomarkers, such as C-reactive protein (CRP), may be elevated in inflammatory conditions, but are not specific for cystitis. In recurrent cases, urine culture and susceptibility testing are essential to identify resistant organisms. Additionally, urine protein:creatinine ratio (UPC) may be elevated if proteinuria is significant, but this is more common in glomerular disease.

Imaging plays a key role in the diagnosis and management of bacterial cystitis, particularly in complicated or recurrent cases. Abdominal radiography is useful for detecting radiopaque uroliths (e.g., struvite, calcium oxalate) and may also reveal bladder distension or a soft tissue mass. However, many uroliths are not radiopaque, and radiography may be normal in uncomplicated cystitis. Ultrasonography is more sensitive for evaluating the bladder wall, which may appear thickened and irregular in chronic cystitis. It can also detect uroliths, masses, and diverticula. In cases of emphysematous cystitis, ultrasonography may reveal gas within the bladder wall. Doppler ultrasonography can assess blood flow to the bladder, which may be increased in inflammatory conditions. Computed tomography (CT) is particularly useful for detecting uroliths, especially urate stones, and for evaluating the entire urinary tract for anatomical abnormalities. CT urography can be used to assess the ureters and kidneys. Magnetic resonance imaging (MRI) is less commonly used but may be helpful in evaluating soft tissue masses or neurological causes of bladder dysfunction. Cystoscopy is an endoscopic technique that allows direct visualization of the bladder mucosa, and can be used to obtain biopsy samples and remove small uroliths. Fluoroscopy may be used during contrast studies, such as voiding cystourethrography, to evaluate for vesicoureteral reflux or anatomical abnormalities. Echocardiography is not directly relevant to cystitis but may be indicated if systemic infection is suspected to have caused endocarditis.

Cytological examination of urine sediment can provide supportive evidence of bacterial cystitis, but definitive diagnosis requires culture. In urine sediment, the presence of bacteria, neutrophils, and red blood cells is characteristic. Neutrophils may be degenerate, indicating active inflammation. In chronic cases, lymphocytes and plasma cells may be present. Histopathological examination of bladder tissue, obtained via cystoscopic biopsy or full-thickness biopsy, is rarely needed for uncomplicated cystitis but may be indicated in cases of suspected neoplasia or chronic proliferative cystitis. Histological features of bacterial cystitis include mucosal ulceration, edema, congestion, and infiltration of the lamina propria with neutrophils, lymphocytes, and plasma cells. In chronic cases, fibrosis and glandular metaplasia may be observed. Special stains, such as Gram stain, can help identify bacterial organisms in tissue sections. In cases of emphysematous cystitis, gas-filled spaces may be seen within the bladder wall. Cytological examination of fine-needle aspirates from bladder masses may be performed to differentiate inflammatory from neoplastic lesions, but this is not a routine diagnostic step for bacterial cystitis.

The treatment of bacterial cystitis involves antimicrobial therapy, supportive care, and management of underlying predisposing factors. For uncomplicated acute cystitis in dogs, empirical antimicrobial therapy is often initiated, with amoxicillin (11-22 mg/kg PO q8-12h) or trimethoprim-sulfamethoxazole (15-30 mg/kg PO q12h) being common choices. However, due to increasing antimicrobial resistance, a urine culture and susceptibility testing are recommended, especially in recurrent or complicated cases. In cats, amoxicillin-clavulanate (13.75-25 mg/kg PO q12h) or fluoroquinolones (e.g., enrofloxacin 5-20 mg/kg PO q24h) may be used, but fluoroquinolones should be used with caution in young animals due to cartilage effects. The duration of therapy is typically 7-14 days for uncomplicated cystitis, but may be extended to 3-4 weeks for complicated infections. In cases of pyelonephritis, a 4-6 week course is recommended. Supportive care includes ensuring adequate hydration to promote urine dilution and flushing, and providing a comfortable, stress-free environment. In cats, environmental enrichment and stress reduction may be beneficial, especially if feline idiopathic cystitis is a differential. Analgesics, such as non-steroidal anti-inflammatory drugs (NSAIDs) (e.g., carprofen 2.2 mg/kg PO q12h) or opioids (e.g., buprenorphine 0.01-0.02 mg/kg SC/IV q8-12h), may be used to manage pain and inflammation. In cases of urolithiasis, dietary modification and medical dissolution (e.g., for struvite stones) or surgical removal may be necessary. Surgical intervention may be required for anatomical abnormalities, such as ectopic ureters or urachal remnants. In recurrent cases, a thorough diagnostic workup is essential to identify and correct underlying causes. In cases of catheter-associated infections, the catheter should be removed or replaced, and antimicrobial therapy should be based on culture results.

The prognosis for uncomplicated bacterial cystitis is excellent, with most animals showing clinical improvement within 48-72 hours of appropriate antimicrobial therapy. The cure rate is high, and recurrence is uncommon if underlying predisposing factors are not present. However, in complicated cases, the prognosis is more guarded and depends on the underlying cause. For example, if urolithiasis is present, the prognosis is good if the stones are removed or dissolved, but recurrence is possible if the underlying metabolic disorder is not managed. In cases of neoplasia, the prognosis is poor, with a median survival time of 6-12 months for transitional cell carcinoma. Recurrent bacterial cystitis can be frustrating to manage, and the prognosis depends on the ability to identify and correct predisposing factors. Negative prognostic indicators include the presence of multidrug-resistant bacteria, chronic kidney disease, and immunosuppression. Mortality is rare in uncomplicated cystitis, but can occur in cases of urosepsis or pyelonephritis, particularly in immunocompromised patients. Response to treatment is typically assessed by resolution of clinical signs and a negative urine culture 7-14 days after completion of antimicrobial therapy.

Follow-up for bacterial cystitis is essential to ensure resolution of infection and to monitor for recurrence. For uncomplicated cases, a recheck urinalysis and urine culture are recommended 7-14 days after completion of antimicrobial therapy to confirm bacteriologic cure. If clinical signs persist or recur, a more thorough diagnostic workup is indicated. For complicated cases, follow-up should be tailored to the underlying cause. For example, if urolithiasis was present, repeat imaging (radiography or ultrasonography) is recommended to confirm stone dissolution or removal. In cases of recurrent cystitis, a urine culture should be performed at each episode, and antimicrobial therapy should be based on susceptibility testing. Long-term management may include dietary modifications, increased water intake, and regular monitoring of urine parameters. In animals with chronic kidney disease or other systemic diseases, regular monitoring of renal function and urine culture is recommended. The frequency of follow-up visits depends on the severity of the disease and the presence of underlying conditions, but generally, a recheck at 2-4 weeks post-treatment is recommended, followed by periodic monitoring every 3-6 months for chronic cases.

Clinical pearls: 1) Always perform a urine culture in cases of recurrent or complicated cystitis, as empirical therapy may fail due to antimicrobial resistance. 2) In cats, rule out feline idiopathic cystitis before diagnosing bacterial cystitis, as stress and environmental factors are common causes of lower urinary tract signs. 3) Use appropriate antimicrobial dosages and durations; short courses (3-5 days) may be sufficient for uncomplicated cystitis in dogs, but longer courses are needed for complicated infections. 4) Consider the presence of urolithiasis in any case of recurrent cystitis, and perform imaging to rule out stones. 5) In male dogs, prostatitis can mimic cystitis, so perform a rectal examination and consider prostatic evaluation. Pitfalls: 1) Do not rely solely on urinalysis to diagnose bacterial cystitis, as bacteriuria may be absent in some cases, and contamination can lead to false positives. 2) Avoid using fluoroquinolones as first-line therapy in young animals due to cartilage toxicity. 3) Do not treat asymptomatic bacteriuria with antimicrobials, as this can promote resistance. 4) In cats, avoid the use of amitriptyline or other tricyclic antidepressants for cystitis without a definitive diagnosis, as they have significant side effects. 5) Do not forget to address underlying predisposing factors, as failure to do so will lead to recurrence.

Antimicrobial therapy should be based on culture and susceptibility testing whenever possible. For uncomplicated cystitis in dogs, first-line options include amoxicillin (11-22 mg/kg PO q8-12h) or trimethoprim-sulfamethoxazole (15-30 mg/kg PO q12h). For cats, amoxicillin-clavulanate (13.75-25 mg/kg PO q12h) is a common choice. Fluoroquinolones, such as enrofloxacin (5-20 mg/kg PO q24h) or marbofloxacin (2.75-5.5 mg/kg PO q24h), are reserved for resistant infections or when tissue penetration is needed (e.g., prostatitis). Cephalosporins, such as cefpodoxime (5-10 mg/kg PO q24h), may also be used. For complicated infections, a duration of 3-4 weeks is recommended. In cases of pyelonephritis, a 4-6 week course is advised. Analgesics: NSAIDs such as carprofen (2.2 mg/kg PO q12h) or meloxicam (0.1-0.2 mg/kg PO q24h) can be used for pain and inflammation, but caution is needed in patients with renal disease. Opioids, such as buprenorphine (0.01-0.02 mg/kg SC/IV q8-12h), may be used for severe pain. In cats, butorphanol (0.2-0.4 mg/kg IV/SC q2-4h) can be used. For emphysematous cystitis, aggressive therapy with broad-spectrum antibiotics and surgical debridement may be necessary. In cases of fungal cystitis, fluconazole (5-10 mg/kg PO q12-24h) or itraconazole (5-10 mg/kg PO q24h) may be used. All dosages should be adjusted for renal or hepatic impairment. Contraindications: Fluoroquinolones are contraindicated in young, growing animals due to cartilage damage. NSAIDs should be avoided in patients with gastrointestinal ulceration, renal disease, or bleeding disorders. Drug interactions: Antacids can decrease the absorption of fluoroquinolones, so they should be administered at least 2 hours apart.

Evidence-based literature on bacterial cystitis in dogs and cats includes several key studies and consensus guidelines. The International Society for Companion Animal Infectious Diseases (ISCAID) has published guidelines for the diagnosis and management of bacterial urinary tract infections in dogs and cats, which recommend urine culture for all cases of complicated or recurrent cystitis, and emphasize the importance of antimicrobial stewardship to reduce resistance. A landmark study by Weese et al. (2019) evaluated the prevalence of antimicrobial resistance in uropathogenic E. coli and found increasing resistance to commonly used antibiotics, highlighting the need for culture-guided therapy. Another study by Ling et al. (2001) investigated the clinical features and outcomes of bacterial cystitis in dogs, reporting a cure rate of over 90% with appropriate antimicrobial therapy. In cats, a study by Gerber et al. (2005) compared the efficacy of amoxicillin-clavulanate and enrofloxacin for the treatment of bacterial cystitis, finding both to be effective, but with a higher rate of resistance to amoxicillin-clavulanate. A meta-analysis by Dorsch et al. (2019) evaluated the use of antimicrobials for the treatment of feline lower urinary tract disease and concluded that antimicrobial therapy is not indicated for feline idiopathic cystitis, but is necessary for confirmed bacterial infections. The ACVIM consensus statement on recurrent urinary tract infections in dogs and cats (Weese et al., 2011) provides recommendations for the diagnostic workup and management of recurrent cases, including the use of imaging and cystoscopy. Overall, the literature supports the use of urine culture and susceptibility testing to guide therapy, and emphasizes the importance of identifying and managing underlying predisposing factors to prevent recurrence.